📰 Nasdaq Dkdca News
Nasdaq Dkdca News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Dkdca. Real-time updates on events, politics, business and more.
February 7, 2024
Westchester Capital Management LLC reduced its holdings in Data Knights Acquisition Corp. (NASDAQ:DKDCA – Free Report) by 43.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 228,588 shares of the company’s stock after selling 178,412 shares during the quarter. Westchester Capital Management LLC’s holdings […]
February 7, 2024
Westchester Capital Management LLC trimmed its stake in Data Knights Acquisition Corp. (NASDAQ:DKDCA – Free Report) by 43.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 228,588 shares of the company’s stock after selling 178,412 shares during the period. Westchester […]
August 18, 2023
Graham Capital Wealth Management LLC boosted its position in shares of Data Knights Acquisition Corp. (NASDAQ:DKDCA – Free Report) by 263.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 184,846 shares of the company’s stock after purchasing an additional 134,002 shares during the quarter. […]
June 5, 2023
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and U.S. Stem Cell (OTCMKTS:USRM – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Profitability This table compares Data Knights Acquisition […]
June 4, 2023
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and IQVIA (NYSE:IQV – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Risk and Volatility Data Knights Acquisition has a beta of […]
June 1, 2023
Data Knights Acquisition Corp. (NASDAQ:DKDCA – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 3,900 shares, an increase of 8.3% from the April 30th total of 3,600 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio […]
May 14, 2023
Data Knights Acquisition Corp. (NASDAQ:DKDCA – Get Rating) saw a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 3,600 shares, a decrease of 47.8% from the April 15th total of 6,900 shares. Approximately 0.1% of the company’s stock are short sold. Based on an […]
May 13, 2023
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and Absci (NASDAQ:ABSI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Earnings & Valuation This table compares Data Knights Acquisition […]
May 7, 2023
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) is one of 40 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare Data Knights Acquisition to related businesses based on the strength of its analyst recommendations, dividends, earnings, institutional ownership, risk, valuation and profitability. Valuation […]
April 30, 2023
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) is one of 40 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its competitors? We will compare Data Knights Acquisition to similar businesses based on the strength of its earnings, profitability, risk, valuation, institutional ownership, dividends and analyst recommendations. Earnings […]